Rossby Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Rossby Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Sell	100 -150	-60%	-$20.3K	﹤0.01%	1032
2026 Q1	$32.1K	Buy	250 +150	+150%	+$18.7K	0.01%	874
2025 Q4	$12.2K	Hold	100	–	–	﹤0.01%	870
2025 Q3	$10.1K	Hold	100	–	–	﹤0.01%	853
2025 Q2	$8.29K	Buy	+100	New	+$7.98K	﹤0.01%	824

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Rossby Financial's XBI Position: Q2 2026 in Review

Rossby Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 60% in Q2 2026, selling an estimated $20.3K and leaving 100 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1032.

Rossby Financial first reported a position in XBI in Q2 2025 and has held it in 5 quarters since. The position peaked at $32.1K in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Rossby Financial held 100 shares of State Street SPDR S&P Biotech ETF worth $15.8K as of Q2 2026.
Rossby Financial sold 150 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $20.3K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1032 holding.
Rossby Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 5 quarters since.
Rossby Financial's State Street SPDR S&P Biotech ETF position peaked at $32.1K in Q1 2026.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.